Understand free testosterone testing methods, why SHBG matters, and which questions to ask about units, reference intervals and clinical context.
How is free testosterone measured? Free testosterone is assessed by equilibrium dialysis, mathematical calculation or direct immunoassay, but these approaches are not interchangeable.
This article is for informational purposes only and is not medical advice. A qualified clinician should guide individual decisions about testing and treatment.
Free testosterone, often shortened to fT, is the portion of circulating testosterone that is not bound to carrier proteins. Understanding that definition is the starting point for reading the result. The next question is how the laboratory obtained it.
The European Association of Urology (EAU) guideline places free testosterone assessment in a specific clinical context. It is particularly useful when total testosterone is near a decision threshold or when sex hormone-binding globulin, known as SHBG, may be altered.
That means the reason for requesting the test matters alongside its name. A clinician may be using it to clarify a total testosterone result or to account for a change in protein binding. Asking what question the test was intended to answer gives the discussion a clearer starting point than focusing only on whether the result is flagged.
The EAU identifies equilibrium dialysis as the most accurate method for measuring free testosterone. It measures free testosterone directly rather than deriving it through a mathematical calculation.
This is a specific recommendation about a named method. It is not a claim that every laboratory result obtained by equilibrium dialysis is perfectly accurate.
For someone reading a report, the useful step is to check whether equilibrium dialysis is explicitly identified in the method description. If the report only lists “free testosterone,” that label does not answer the method question.
A focused question for the laboratory is: “Was this result measured by equilibrium dialysis?” The answer establishes which assessment method was used before the conversation moves to the result itself. There is no need to infer the method from the test name or from the presence of a reference interval.
Calculated free testosterone is an estimate derived from other laboratory results. It uses measured total testosterone and SHBG, with albumin also included in commonly used calculations. The EAU recognizes calculations that account for SHBG and albumin as an alternative to equilibrium dialysis.
The distinction is straightforward: a calculated result is not a separate direct measurement of free testosterone. It is the output of a formula that uses other information.
Its interpretation therefore depends on the inputs and the calculation method. Results should not be assumed equivalent simply because they are all described as calculated free testosterone.
Useful questions include:
These questions help identify what the estimate represents without requiring the reader to reproduce the calculation. Testostra’s explanation of how free testosterone assessment methods differ provides additional context for the terminology.
The practical aim is to make the calculation traceable. A clinician or laboratory can clarify the method more reliably than a reader can infer it from the final number alone.
The EAU advises against direct free testosterone estimation using available immunoassays because it considers these methods inaccurate. That warning concerns a particular way of assessing free testosterone.
It should not be broadened into the claim that every free testosterone test is inaccurate. Equilibrium dialysis and calculation are separate approaches in the guideline.
The word “direct” also needs care. Equilibrium dialysis is a direct measurement method, but that does not make it the same procedure as a direct free testosterone immunoassay. The full method name matters more than the word alone.
If a report identifies a direct immunoassay, the relevant discussion is how the clinician will assess that result in light of the guideline’s concern. A useful question is: “Does this method provide a suitable basis for interpreting my free testosterone?” That keeps the issue focused on the test rather than treating its label as proof of quality.
SHBG is a carrier protein that helps explain why total testosterone and free testosterone may need to be considered together. According to the EAU guideline, unusually high or low SHBG can make a total testosterone result harder to interpret because the total level may change with SHBG.
The guideline associates ageing and hyperthyroidism with increased SHBG. It also lists hepatic disease, smoking and some medications among the associated factors.
Factors associated with decreased SHBG include obesity and insulin resistance. Hypothyroidism and several medications are also listed.
These associations provide context for medical review. They do not establish why an individual person’s SHBG result is high or low.
The EAU recommends measuring SHBG and calculating free testosterone when indicated. It does not present this assessment as necessary for every man. The useful clinical question is whether altered SHBG could affect the interpretation of the total testosterone result in this particular assessment.
For a fuller explanation of the relationship, see how SHBG changes the interpretation of total and free testosterone. Keeping these measurements connected is more informative than treating each as an unrelated number.
Start with the reporting details rather than placing the numbers side by side. The research-supported approach is to identify the method, units and laboratory-specific reference interval for each result.
The reference interval supplies the laboratory’s comparison context. The EAU notes that commercial immunoassay ranges may have unclear reference populations and conditions before analysis. It also advises close collaboration between clinicians and laboratories to support accurate and comparable measurement.
This is a reason to clarify the report, not to dismiss laboratory reference ranges as universally unreliable.
A useful report-reading checklist is:
The practical rule is to avoid treating differently reported values as directly comparable until these details are clear. If information is missing, the clinician or laboratory can help resolve it.
The goal is not to choose whichever report appears more reassuring. It is to establish what each result represents before drawing a conclusion about the difference.
The EAU says assessment for hypogonadism should combine signs and symptoms with consistently low serum testosterone. A free testosterone value alone does not establish that diagnosis.
A physician therefore considers the testing questions collectively. The reason for requesting free testosterone belongs alongside the total testosterone findings and relevant SHBG information. The measurement method then helps establish how the free testosterone result should be understood.
This approach connects the laboratory discussion to the clinical question. It also avoids asking a single number to explain every reported concern.
Useful topics for the appointment include why the test was requested and whether its method is clear. Another is how the finding fits with the symptoms being assessed. Decisions about further evaluation belong with a qualified clinician who can review the individual situation.
Testostra’s guide to framing questions around a testosterone report offers a related way to organize that conversation. The emphasis is on understanding the assessment rather than assigning a diagnosis from a flagged result.
Bring the discussion back to a small set of concrete questions:
These questions give the appointment a practical focus. They help separate identifying the test from interpreting its significance.
The clinical takeaway is to understand the result’s origin before deciding what it means. Equilibrium dialysis, calculation and direct immunoassay describe different approaches rather than interchangeable labels. Knowing which was used makes the next conversation more precise.
Could future research make results from different free testosterone methods easier to compare while preserving the clinical context each result needs?
Understanding a free testosterone result requires attention to its method as well as the accompanying biomarkers. Testostra explains how SHBG relates to total and free testosterone, helping men understand laboratory terminology and prepare clearer clinical questions through evidence-led education rather than personal diagnosis or hormone protocols.
Testostra follows testosterone research, clinical guidance and emerging evidence without turning general information into personal treatment advice.
Send us a question, research idea or topic suggestion. Reader questions help shape future Testostra content.
Contact Testostra